Posterior chamber implantation of a Preserflo Microshunt in a patient with a compromised endothelium.
Arch Soc Esp Oftalmol (Engl Ed)
; 97(3): 161-164, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-35248397
ABSTRACT
The objective of the present case is to describe a variation in the Preserflo Microshunt surgical technique, placing it in the posterior chamber to minimise the risk of endothelial cell loss in cases with a compromised endothelium. The patient was a 72-year-old pseudophakic woman, with granular dystrophy and a primary diagnosis of open-angle glaucoma presenting with a progressive visual field defect and an IOP of 26 mmHg with maximal medical therapy. The cornea had incipient stromal folds with an endothelial count of 700â¯cells/mm2. A Preserflo Microshunt was implanted in the posterior chamber to minimise the possibility of further damage to the corneal endothelium. Six months after surgery, the implant remains functional. The IOP is 9â¯mmHg without medications. As far as we know, this is the first Preserflo implanted in the posterior chamber described in the literature.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Glaucoma de Ángulo Abierto
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Arch Soc Esp Oftalmol (Engl Ed)
Año:
2022
Tipo del documento:
Article